Systemic immunity in cancer

KJ Hiam-Galvez, BM Allen, MH Spitzer - Nature reviews cancer, 2021 - nature.com
Immunotherapy has revolutionized cancer treatment, but efficacy remains limited in most
clinical settings. Cancer is a systemic disease that induces many functional and …

Tumor-infiltrating natural killer cells

B Cózar, M Greppi, S Carpentier, E Narni-Mancinelli… - Cancer discovery, 2021 - AACR
Because of their potent antitumor activity and their proinflammatory role, natural killer (NK)
cells are at the forefront of efforts to develop immuno-oncologic treatments. NK cells …

Dual effect of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers

AC Peña-Romero, E Orenes-Piñero - Cancers, 2022 - mdpi.com
Simple Summary The relationship between the immune system and tumours is currently one
of the most studied topics in the field of cancer. Previously, it was thought that a tumour could …

Influence of the tumor microenvironment on NK cell function in solid tumors

O Melaiu, V Lucarini, L Cifaldi, D Fruci - Frontiers in immunology, 2020 - frontiersin.org
Natural killer (NK) cells are a population of innate lymphoid cells playing a pivotal role in
host immune responses against infection and tumor growth. These cells have a powerful …

The natural cytotoxicity receptors in health and disease

AD Barrow, CJ Martin, M Colonna - Frontiers in immunology, 2019 - frontiersin.org
The Natural Cytotoxicity Receptors (NCRs), NKp46, NKp44, and NKp30, were some of the
first human activating Natural Killer (NK) cell receptors involved in the non-MHC-restricted …

Targeting natural killer cells in cancer immunotherapy

C Guillerey, ND Huntington, MJ Smyth - Nature immunology, 2016 - nature.com
Alteration in the expression of cell-surface proteins is a common consequence of malignant
transformation. Natural killer (NK) cells use an array of germline-encoded activating and …

[HTML][HTML] The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology

J Wienke, MP Dierselhuis, GAM Tytgat… - European journal of …, 2021 - Elsevier
Immunotherapy holds great promise for the treatment of pediatric cancers. In neuroblastoma,
the recent implementation of anti-GD2 antibody Dinutuximab into the standard of care has …

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

B Besse, M Charrier, V Lapierre, E Dansin… - …, 2016 - Taylor & Francis
Dendritic cell-derived exosomes (Dex) are small extracellular vesicles secreted by viable
dendritic cells. In the two phase-I trials that we conducted using the first generation of Dex …

Dendritic cell–derived exosomes for cancer therapy

JM Pitt, F André, S Amigorena, JC Soria… - The Journal of …, 2016 - Am Soc Clin Investig
DC-derived exosomes (Dex) are nanometer-sized membrane vesicles that are secreted by
the sentinel antigen-presenting cells of the immune system: DCs. Like DCs, the molecular …

The function of NK cells in tumor metastasis and NK cell-based immunotherapy

Y Yu - Cancers, 2023 - mdpi.com
Simple Summary Innate immune natural killer (NK) cells are capable of killing metastatic
cancer cells without activation by antigen-presenting cells beforehand. The cytotoxic effects …